Principal Medical Director, Neuroscience

Genentech; California; On-site; USD 250,000 - 380,000; Full time

Job summary

Genentech seeks a Principal Medical Director to lead late-stage neuroscience development strategies. The role requires an MD/MBBS/MD/PhD with neurology board certification and extensive global CDP experience, overseeing regulatory interactions and cross-functional teams across US sites.

On-site in SF, with potential remote US work, the position influences study design, endpoints, and regulatory submission strategies.

Qualifications

• MD/MBBS/MD/PhD with Neurology board certification.
• 7+ years pharma/biotech R&D in late development.
• Experience authoring global CDPs and FDA/EMA interactions.
• Expertise in Phase II–III development and regulatory submissions.

Responsibilities

• Lead the Clinical Development strategy and plan for assigned molecules.
• Guide end-to-end drug development and regulatory alignment.
• Mentor physicians and scientists in disease area expertise.
• Collaborate with cross-functional teams and health authorities.

Skills

Clinical trial leadership

MS development experience

Global CDP strategy

Regulatory interactions

Cross-functional leadership

Education

MD/MBBS/MD PhD

Board Certified in Neurology

Job description

We advance science so that we all have more time with the people we love.

Roche's Clinical Development organization is structured by therapeutic area and is responsible for developing and executing the late development clinical strategies and plans that deliver medically differentiated therapies that provide meaningful improvement to patients.

Roche is looking for an experienced and highly specialized individual to join the Neuroscience, MS group. The role of Principal Medical Director will focus on guiding the development within one of our Neuroscience portfolios. The ideal candidate will have experience in late stage drug development and a demonstrated level of collaboration experience with cross-functional teams. The Principal Medical Director position requires a strong understanding of neuroscience diseases, clinical trial protocols, regulatory requirements, and possibly interactions with regulatory agencies to ensure studies meet the required standards.

The Principal Medical Director leads development of the Clinical Development (CD) strategy and is responsible for developing the CD plan and ensuring effective and efficient execution for assigned molecule(s)/indication(s). Principal Medical Directors are expected to act as CD leaders, perform their responsibilities independently, and effectively lead multiple projects.

You will interact with the highest levels of management and experts both internally and externally, serving as internal consultants to Roche committees as well as representing the therapeutic area's CD strategy, plans, objectives and interests to health authorities (HAs) and prominent thought leaders.

You are expected to provide critical insights and contributions to the overall development and effectiveness of the assigned therapeutic area(s), including therapeutic area scientific strategies and plans.

You have demonstrated a high level of experience in Clinical Development Plan (CDP) Strategy & Planning, CDP Execution, Regulatory Activities, and Cross-Functional Team Leadership.

You will oversee the end-to-end (E2E) drug delivery device strategy (where appropriate) for programs in your franchise and ensure each strategy is integrated within the overall clinical development plan and asset strategy for the assigned molecule to ensure seamless execution and regulatory alignment.

You will mentor other physicians / scientists in their disease area of expertise.

This position will be based on-site in San Francisco, CA; Boston, MA or remotely within the US. Relocation benefits are not available for this role.

Who You Are (Required)

• You have an MD, MBBS or MD (MBBS)/PhD, Board Certified in Neurology; along with significant clinical trial/development experience in MS studies.
• You have 7+ years of pharma/biotech R&D experience across all phases of development; including experience working with global teams internally and externally
• You have experience authoring global clinical development plans and working with various health authorities; (i.e. have led successful interactions with the FDA, EMA and other health authorities, including a filing.)
• You have extensive understanding of Phase II - III drug development (e.g trials across different stages of development, or formal education/qualifications in pharmaceutical medicine or drug development); have made significant contributions to an organization's drug development (whether at Roche or another organization); have identified and created clinical development strategies that have led to label‑enabling outcomes
• You have significant regulatory experience: providing clinical science information and input for regulatory submissions and other regulatory process: experience leading/overseeing others in development of briefing packages by providing clinical science information and input; experience leading/overseeing others in development of interactions and responses to health authority (HA) questions by providing clinical science information and input; other team members, regulatory and other internal partners/stakeholders in the completion and submission of regulatory filings and other regulatory documentation

Preferred

• You have in-depth knowledge of the pharma/biotech industry, the multiple functions and roles involved in the drug development process.
• You have championed novel/innovative approaches to clinical development (i.e. study design, endpoints, technology)
• You have the ability to collaborate on enterprise level strategic initiatives with a variety of internal and external partners and stakeholders, such as clinical investigators, clinicians, scientists and key opinion leaders (KOLs), as well as multidisciplinary internal groups, including other groups in the Roche/Genentech Product Development team: research, business development, commercial operations, legal, etc, resulting in demonstrable outcomes (e.g. new study proposals or new disease indications) and make major visible contributions to the local site community and the PDC gl